1. |
中华医学会眼科学分会眼免疫学组. 中国葡萄膜炎诊疗中眼内液检测专家共识(2020年)[J]. 中华眼科杂志, 2020, 56(9): 657-661. DOI: 10.3760/cma.j.cn112142-20200305-00141.Eye Immunology Group, Ophthalmology Branch of Chinese Medical Association. Expert consensus on intraocular fluid detection in the diagnosis and treatment of uveitis in China (2020)[J]. Chin J Ophthalmol, 2020, 56(9): 657-661. DOI: 10.3760/cma.j.cn112142-20200305-00141.
|
2. |
张晓光, 杨计军, 刘磊, 等. 地塞米松玻璃体内植入剂治疗非感染性葡萄膜炎继发黄斑水肿的研究进展[J]. 国际眼科杂志, 2020, 20(2): 258-262. DOI: 10.3980/j.issn.1672-5123.2020.2.14.Zhang XG, Yang JJ, Liu L, et al. Researchprogress of intravitreal dexamethasone implant in the treatment of non-infectious uveitic macular edema[J]. Int Eye Sci, 2020, 20(2): 258-262. DOI: 10.3980/j.issn.1672-5123.2020.2.14.
|
3. |
Correia de Sousa M, Gjorgjieva M, Dolicka D, et al. Deciphering miRNAs' action through miRNA editing[J/OL]. Int J Mol Sci, 2019, 20(24): 6249[2019-12-11]. https://pubmed.ncbi.nlm.nih.gov/31835747/. DOI: 10.3390/ijms20246249.
|
4. |
Pockar S, Globocnik Petrovic M, Peterlin B, et al. MiRNA as biomarker for uveitis: a systematic review of the literature[J]. Gene, 2019, 696: 162-175. DOI: 10.1016/j.gene.2019.02.004.
|
5. |
Wei Y, Li N, Zhao L, et al. MicroRNAs and autoimmune-mediated eye diseases[J/OL]. Front Cell Dev Biol, 2020, 8: 818[2020-08-20]. https://pubmed.ncbi.nlm.nih.gov/32974350/. DOI: 10.3389/fcell.2020.00818.
|
6. |
Bouzeyen R, Haoues M, Barbouche MR, et al. FOXO3 transcription factor regulates IL-10 expression in mycobacteria-infected macrophages, tuning their polarization and the subsequent adaptive immune response[J/OL]. Front Immunol, 2019, 10: 2922[2019-12-12]. https://pubmed.ncbi.nlm.nih.gov/31921181/. DOI: 10.3389/fimmu.2019.02922.
|
7. |
Ishida W, Fukuda K, Higuchi T, et al. Dynamic changes of microRNAs in the eye during the development of experimental autoimmune uveoretinitis[J]. Invest Ophthalmol Vis Sci, 2011, 52(1): 611-617. DOI: 10.1167/iovs.10-6115.
|
8. |
Caspi RR. Experimental autoimmune uveoretinitis in the rat and mouse[J/OL]. Curr Protoc Immunol, 2003, 15(1): 15[2003-05-01]. https://pubmed.ncbi.nlm.nih.gov/18432901/. DOI: 10.1002/0471142735.im1506s53.
|
9. |
Couret C, Ducloyer JB, Touhami S, et al. Traitement des uvéites intermédiaires, postérieures et panuvéites non infectieuses [Treatment of noninfectious intermediate uveitis, posterior uveitis, or panuveitis][J]. J Fr Ophtalmol, 2020, 43(4): 341-361. DOI: 10.1016/j.jfo.2019.03.033.
|
10. |
曹绪胜, 王红, 彭晓燕. 经组织病理学检查确诊的结节病葡萄膜炎的临床特征[J]. 中华医学杂志, 2020, 100(32): 2498-2502. DOI: 10.3760/cma.j.cn112137-20200426-01323.Cao XS, Wang H, Peng XY. Clinical features of sarcoid uveitis diagnosed by histopathological examination[J]. Nat Med J China, 2020, 100(32): 2498-2502. DOI: 10.3760/cma.j.cn112137-20200426-01323.
|
11. |
郑雅. MicroRNA调控Th17/Treg平衡的研究进展[J]. 医学研究生学报, 2020, 33(6): 651-657. DOI: 10.16571/j.cnki.1008-8199.2020.06.018.Zheng Y. Advances in miRNA regulation of Th17/Treg balance[J]. J Med Postgra, 2020, 33(6): 651-657. DOI: 10.16571/j.cnki.1008-8199.2020.06.018.
|
12. |
Tiwari A, Mukherjee B, Dixit M. MicroRNA key to angiogenesis regulation: miRNA biology and therapy[J]. Curr Cancer Drug Targets, 2018, 18(3): 266-277. DOI: 10.2174/1568009617666170630142725.
|
13. |
O' Rourke M, Trenkmann M, Connolly M, et al. Novel gene targets for miRNA146a and miRNA155 in anterior uveitis[J]. Br J Ophthalmol, 2019, 103(2): 279-285. DOI: 10.1136/bjophthalmol-2018-312885.
|
14. |
Verhagen FH, Bekker CPJ, Rossato M, et al. A disease-associated microRNA cluster links inflammatory pathways and an altered composition of leukocyte subsets to noninfectious uveitis[J]. Invest Ophthalmol Vis Sci, 2018, 59(2): 878-888. DOI: 10.1167/iovs.17-23643.
|
15. |
Asakage M, Usui Y, Nezu N, et al. Comprehensive miRNA analysis using serum from patients with noninfectious uveitis[J/OL]. Invest Ophthalmol Vis Sci, 2020, 61(11): 4[2020-09-01]. https://pubmed.ncbi.nlm.nih.gov/32876691/. DOI: 10.1167/iovs.61.11.4.
|
16. |
Han J, Park SY, Ahn YH, et al. MicroRNA-142-5p is up-regulated on allogeneic immune responses and up-regulates MHC Class Ⅱ expression in human umbilical vein endothelial cells[J/OL]. Transplant Proc, 2020, 1345(20): 30464[2020-06-29]. https://pubmed.ncbi.nlm.nih.gov/32616346/. DOI: 10.1016/j.transproceed.2020.05.024.
|
17. |
Talebi F, Ghorbani S, Chan WF, et al. MicroRNA-142 regulates inflammation and T cell differentiation in an animal model of multiple sclerosis[J/OL]. J Neuroinflammation, 2017, 14(1): 55[2017-03-16]. https://pubmed.ncbi.nlm.nih.gov/28302134/. DOI: 10.1186/s12974-017-0832-7.
|
18. |
Xu C, Tian LH. LncRNA XIST promotes proliferation and epithelial-mesenchymal transition of retinoblastoma cells through sponge action of miR-142-5p[J]. Eur Rev Med Pharmacol Sci, 2020, 24(18): 9256-9264. DOI: 10.26355/eurrev_202009_23007.
|
19. |
Wei Y, Chen S, Sun D, et al. miR-223-3p promotes autoreactive Th17 cell responses in experimental autoimmune uveitis (EAU) by inhibiting transcription factor FOXO3 expression[J]. FASEB J, 2019, 33(12): 13951-13965. DOI: 10.1096/fj.201901446R.
|